Changes in liver enzymes and association with prognosis in patients with COVID-19: a retrospective case-control study

Farhad Shaveisi-Zadeh1, Bahram Nikkho2, Mohamaad Bagher Khadem Erfan3

  • 1Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Insights

This study investigated COVID-19 patient lab results, finding elevated liver enzymes (ALT) and altered blood cell counts. However, these markers did not correlate with patient mortality, suggesting caution in attributing liver damage solely to SARS-CoV-2.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Hematology

Background:

  • COVID-19 poses a significant global health risk.
  • Understanding the laboratory manifestations of COVID-19 is crucial for patient management.
  • Liver enzyme alterations are frequently observed in COVID-19 patients.

Purpose of the Study:

  • To examine laboratory investigations in COVID-19 patients.
  • To specifically analyze liver enzyme levels in relation to COVID-19 infection.
  • To investigate the association between laboratory findings and patient survival.

Main Methods:

  • Retrospective, single-center study of 77 COVID-19 patients.
  • Analysis of complete blood cell count, WBC, NLR, PLR, LMR, ALT, and alkaline phosphatase.
  • Comparison of laboratory findings between COVID-19 patients and 63 healthy controls.

Main Results:

  • COVID-19 patients exhibited elevated ALT, WBC, neutrophils, NLR, and PLR compared to controls.
  • Patients with COVID-19 showed decreased platelet counts and lymphocytes.
  • Elevated AST, NLR, PLR, and LMR were observed but not linked to mortality.

Conclusions:

  • While certain laboratory markers are altered in COVID-19, they do not predict mortality.
  • Elevated AST levels in COVID-19 patients require careful interpretation due to AST presence in other tissues.
  • Further research is needed to clarify the direct impact of SARS-CoV-2 on liver function.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
933
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
199
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
124